Retatrutide – 30mg

4,339kr

+ Free Shipping

Retatrutide – Multi-agonist peptide for weight loss and metabolic health

What is Retatrutide?
Retatrutide is an advanced peptide that acts on multiple hormone receptors simultaneously (GLP-1, GIP and glucagon) . It is being developed for the treatment of obesity, type 2 diabetes and metabolic diseases . By stimulating these three receptors, Retatrutide can:

Reduce appetite
Increase the feeling of satiety
Improve glucose metabolism
Increase fat burning

Clinical studies show up to 24% weight loss after long-term use, making Retatrutide one of the most promising metabolic peptides under evaluation.

Kategorier: För viktminskning, Peptider

Beskrivning
Recensioner (0)

Peptide Profile
Peptide Name: Retatrutide
CAS Number: 2381089-83-2
Molecular Formula: C221H342N46O68
Form: Lyophilized powder in vial – 30 mg (not pen)

Main function: Multi-agonist for weight loss and metabolic optimization

Mechanism of action: Activates GLP-1, GIP and glucagon receptors for appetite control, glucose regulation and fat burning

Key benefits

Triple receptor activation for maximum weight loss
Up to 24% fat loss in clinical studies
Improves blood sugar and insulin resistance
Lowers LDL cholesterol and triglycerides
Supports liver health (NAFLD/NASH research)
Reduces cardiovascular risk factors
Increases energy, metabolism and vitality

Recommended use and handling

NOTE: The product is supplied as a powder in a bottle (30 mg) and is not a finished pen.

Requires reconstitution before use
Sterile needles and syringes are needed (available to order separately on the page)
Reconstitution is done with sterile sodium chloride solution (NaCl 0.9%)

Reconstitution principle (overview):
The powder is dissolved by carefully adding an appropriate amount of sterile NaCl to the vial. The liquid should be injected slowly along the glass wall and then dissolved gently without vigorous shaking until a clear solution is obtained.

Important:
Exact volume, concentration and further use should be determined by qualified personnel according to research protocol.

Clinical studies

Phase 1 & 2: Showed 15–24% weight reduction over 48 weeks with gradual appetite control. Improved glucose control and lipid profile were observed.

Phase 3: Ongoing to confirm long-term effects on weight, cardiovascular risks and liver function (NAFLD/NASH).

Results:

Significant and sustained weight loss
Improved insulin resistance and glucose levels
Reduced appetite and increased satiety
Lowered LDL cholesterol and triglycerides
Improved liver and heart health

Possible side effects

Mild to moderate nausea (common at the beginning)
Vomiting, diarrhea, or constipation when the dose is increased
Fatigue or weakness in the early stages
Slight increase in heart rate with activity

Most side effects are transient and manageable with dose adjustment.

Summary

Retatrutide is a groundbreaking multi-agonist peptide that offers:

Effective and sustainable fat loss
Improved metabolic control and glucose regulation
Support for liver and heart health
Increased energy and metabolism

Target group:

People with obesity or type 2 diabetes
Athletes looking to optimize body composition and metabolism
Those seeking long-term fat loss, improved endurance and anti-aging effects

Important information

The product is under clinical development.
For research purposes only (Research Use Only)
Not approved for human consumption
Not intended for medical use

Recensioner

Det finns inga recensioner än.

Bli först med att recensera ”Retatrutide – 30mg”